Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Traws Pharma (TRAW) over the last 13 years, with Q3 2025 value amounting to 2.57%.

  • Traws Pharma's Return on Capital Employed rose 233400.0% to 2.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.57%, marking a year-over-year increase of 233400.0%. This contributed to the annual value of 11.59% for FY2024, which is 106500.0% down from last year.
  • Latest data reveals that Traws Pharma reported Return on Capital Employed of 2.57% as of Q3 2025, which was up 233400.0% from 2.03% recorded in Q2 2025.
  • Over the past 5 years, Traws Pharma's Return on Capital Employed peaked at 0.32% during Q4 2021, and registered a low of 26.29% during Q4 2024.
  • Its 5-year average for Return on Capital Employed is 5.0%, with a median of 0.92% in 2023.
  • As far as peak fluctuations go, Traws Pharma's Return on Capital Employed plummeted by -249900bps in 2024, and later surged by 233400bps in 2025.
  • Over the past 5 years, Traws Pharma's Return on Capital Employed (Quarter) stood at 0.32% in 2021, then tumbled by -83bps to 0.59% in 2022, then tumbled by -122bps to 1.3% in 2023, then plummeted by -1926bps to 26.29% in 2024, then soared by 90bps to 2.57% in 2025.
  • Its last three reported values are 2.57% in Q3 2025, 2.03% for Q2 2025, and 12.26% during Q1 2025.